Equity

6 Months Ended

Jun. 30, 2022

Equity [Abstract]

Equity

Note 6. Equity

Common Stock

At June 30, 2022, the Company had 500,000,000 authorized shares of common stock with a par value of $0.00001 per share and 87,352,364 shares of common stock outstanding.

Warrants

The Company has issued warrants to purchase common stock at various exercise prices in connection with loan agreements and private placements. The following table summarizes information about warrants outstanding at June 30, 2022 and December 31, 2021:

	Shares of Common Stock Issuable from Warrants Outstanding as of				Weighted
	June 30,		December 31,		Average
Description	2022		2021		Exercise Price		Expiration
Series F		-		7,246	$	3.45		February 23, 2022
Series G		460,250		460,250	$	2.68		July 21, 2022
Series H		910,000		910,000	$	2.75		October 16, 2022
Series I		10,335,000		10,335,000	$	2.00		November 26, 2025
Total		11,705,250		11,712,496

No warrants were exercised during the three months ended June 30, 2022.

Stock Options

The following table summarizes stock option activity for the six months ended June 30, 2022:

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2021		3,139,999			2.17
Granted		-			-
Forfeited		(115,000	)		2.23
Outstanding at June 30, 2022		3,024,999			2.17
Outstanding at June 30, 2022		3,024,999			2.17		4.04 years		-
Vested and exercisable at June 30, 2022		2,674,999			2.03		4.05 years		-